BioRem Inc. (TSXV:BRM)
Canada · Delayed Price · Currency is CAD 3.440
0.00 (-1.16%)
Sep 18, 2026, 11:30 AM EST
BioRem Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 55 | 44 | 49 | 16 | 14 | 14 | |
Market Cap Growth | 70.28% | -11.49% | 213.21% | 15.10% | -2.10% | -33.28% |
Enterprise Value | 50 | 38 | 46 | 17 | 15 | 5 |
Last Close Price | 3.40 | 2.70 | 3.05 | 1.00 | 0.88 | 0.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.10 | 9.04 | 16.15 | 7.20 | 8.46 | 10.74 |
Forward PE | 8.83 | 10.39 | - | - | - | - |
PS Ratio | 1.09 | 1.03 | 1.31 | 0.62 | 0.47 | 0.57 |
PB Ratio | 3.14 | 2.92 | 4.63 | 2.34 | 3.02 | 7.09 |
P/TBV Ratio | 3.14 | 2.92 | 4.63 | 2.34 | 3.02 | 7.09 |
P/FCF Ratio | 5696.06 | 5.99 | 14.84 | - | 10.98 | 3.76 |
P/OCF Ratio | 167.88 | 5.70 | 13.34 | 32.03 | 9.44 | 3.68 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.99 | 0.90 | 1.22 | 0.67 | 0.52 | 0.19 |
EV/EBITDA Ratio | 5.77 | 5.54 | 9.76 | 5.14 | 5.01 | 1.90 |
EV/EBIT Ratio | 6.06 | 5.82 | 10.38 | 5.46 | 5.21 | 2.02 |
EV/FCF Ratio | 5211.06 | 5.26 | 13.77 | - | 12.09 | 1.27 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.14 | 0.19 | 0.34 | 0.62 | 1.05 | 2.88 |
Debt / EBITDA Ratio | 0.29 | 0.40 | 0.73 | 1.21 | 1.47 | 2.12 |
Debt / FCF Ratio | 257.52 | 0.39 | 1.07 | - | 3.82 | 1.53 |
Net Debt / Equity Ratio | -0.27 | -0.58 | -0.16 | 0.28 | 0.22 | 0.61 |
Net Debt / EBITDA Ratio | -0.55 | -1.25 | -0.35 | 0.58 | 0.32 | 0.48 |
Net Debt / FCF Ratio | -485.00 | -1.19 | -0.50 | -30.13 | 0.78 | 0.32 |
Asset Turnover | 1.62 | 1.36 | 1.42 | 1.12 | 1.45 | 1.19 |
Inventory Turnover | 17.95 | 13.85 | 14.38 | 20.28 | 22.46 | 19.76 |
Quick Ratio | 1.62 | 1.62 | 1.34 | 1.18 | 1.24 | 1.10 |
Current Ratio | 2.04 | 1.85 | 1.63 | 1.41 | 1.38 | 1.22 |
Return on Equity (ROE) | 43.57% | 37.70% | 35.10% | 38.78% | 49.75% | 16.75% |
Return on Assets (ROA) | 16.58% | 13.24% | 10.44% | 8.61% | 9.02% | 7.09% |
Return on Invested Capital (ROIC) | 60.28% | 65.75% | 36.67% | 34.19% | 45.04% | 34.45% |
Return on Capital Employed (ROCE) | 42.90% | 38.50% | 32.60% | 30.30% | 36.90% | 39.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 11.27% | 11.07% | 6.19% | 13.88% | 11.83% | 9.31% |
FCF Yield | 0.02% | 16.71% | 6.74% | -0.40% | 9.10% | 26.60% |
Buyback Yield / Dilution | 1.13% | 0.40% | -19.41% | 10.72% | 53.08% | 5.32% |